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Background: Background: Acute coronary syndromes (ACS) for ST elevation
(STEACS) and non-ST elevation (NSTEACS) are known to be caused by acute
coronary plaque disruption plus thrombus formation resulting in acute myocardial
ischemia. Chronic, totally occluded (CTO) arteries are believed to represent a stable
clinical picture with myocardial ischemia occurring in a predictable pattern. Whether
CTO alone can be the cause of ACS, particularly NSTEACS is unknown as is if
patients (pts) with a CTO are at increased risk for repeat episodes of NSTEACS.
Methods: Methods: TheMinneapolis Heart Institute developed a standardized protocol
to identify and treat high risk NSTEACS pts, the Level Two program (L2). L2 pts are
deﬁned as presentingwith acute anginal symptoms and any of the following: ST segment
depression > 2mm, Anterior T wave inversion, positive biomarkers, recent positive
stress test, or clinical instability as the result of arrhythmia, congestive heart failure, or
ongoing symptoms despite medical therapy. If no other cause for NSTEACS was found
(no signiﬁcant coronary lesions or situations resulting in abrupt increase of myocardial
oxygen demand), theCTOwas considered the cause. The frequencywithwhich these pts
were readmitted for NSTEACS with no new cause within 18 months was assessed.
Results: Results: In 2012, 369 consecutive L2 pts diagnosed with NSTEACS and
underwent coronary angiography. Of the 99 pts found to have a CTO, 21 were deemed to
have NSTEACS caused by the CTO itself as it was the only culprit lesion. These 21 pts
were compared to thosewithout a CTO (n¼270). The readmission rate for ptswith a CTO
culprit lesion was higher than those pts without a CTO (47.6% vs. 23.7%; p ¼ 0.015).
Conclusions: Conclusion: These data demonstrate that CTO can be the cause of
NSTEACS and do not only represent "stable" CAD and that almost 50% these pts
develop repeat episodes of NSTEACS within 18 months.Diagnosed with NSTEACS (n = 369)
Readmitted with NSTEACS within 18 months Not readmitted with NSTEACS within 18 months
NSTEACS due to CTO NSTEACS not due to CTO NSTEACS due to CTO NSTEACS due to CTO
n ¼ 10 n ¼ 64 n ¼ 11 n ¼ 206
(10/21, 47.6%) (64/270, 23.7%) (11/21, 52.4%) (206/270, 76.3%)
Readmission within 18 months was signiﬁcantly higher for patients diagnosed with NSTEACS
due to CTO than those diagnosed with NSTEACS not due to CTO (47.6% vs. 23.7%; p ¼ 0.015)TCT-383
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Background: The hybrid approach to chronic total occlusion (CTO) angioplasty was
devised in 2011. The intent of the hybrid approach was to enhance ﬁrst time procedural
success by harmonizing antegrade and retrograde techniques. . In this algorithm, failing
strategies aregivenupearly andpenetration into the algorithmdictates further strategy.We
sought to describe CTO-PCI technical and procedural success before and after hybrid
approach adoption at two high volume CTO angioplasty centers in the United States.
Methods: Between Jan 1 2009 and Feb 22 2013 660 CTO-PCI procedures were
performed at Peace Health Medical Center, Bellingham WA ;Piedmont Heart Institute,
Atlanta GA; VA Medical Center Dallas TX and Banner Good Samaritan Hospital in
Phoenix AZ by experienced CTO operators. 462 procedures were performed in the
pre-Hybrid era and 198 in the Hybrid era. Technical and procedural success rates were
compared by Fisher's exact test. A p<0.05 was considered signiﬁcant.
Results: Baseline clinical and angiographic characteristics were similar between the two
groups (p>0.05 for all comparisons) Technical failure rates were signiﬁcantly higher in
the pre Hybrid era than the Hybrid era (22.2% v. 4.5%, p¼.001).Likewise, procedural
failure was higher in the pre-Hybrid compared to hybrid era (20.5% v. 11.5%, p¼.001).Table 1
Baseline Characteristics Pre-Hybrid era (N=462, group 1) Hybrid era(N=198, group 2)
Age (years) 65 65.4
Men(%) 312(84.2) 168(85)
Hypertension 345(92) 183(92)
Hyperlipidemia 364(97.6) 195(99)
Diabetes 169(45) 83(42)
EF (<40%) 68(18) 47(24)
History of MI 176(47.7) 89(45)
History of CABG 188(50) 73(37)
B120 JACC Vol 62/18S1/Suppl B j October 27–NConclusions: Adoption of the Hybrid approach to CTO was associated with improved
technical and procedural success in CTO-PCI at high volume centers.
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Background: Chronic total coronary occlusion (CTO) is a frequent ﬁnding in patients
with ischemic heart disease. Our aim was to evaluate the prognostic impact of CTO on
long-term survival in patients with different categories of ischemic heart disease at the
level of one whole nation.
Methods: The study population included all consecutive patients registered in the
SCAAR registry (Swedish Coronary Angiography and Angioplasty Registry) from
2005 to 2012 who underwent angiography or PCI in Sweden. Patients with previous
coronary artery bypass graft surgery were excluded. The patients with CTO and
without CTO (no-CTO) were compared using Cox proportional-hazards regression
adjusted for the following covariates: age, indication, extent of coronary artery
disease, smoking, hypertension, hyperlipidemia, diabetes, year of intervention, prior
infarction, prior PCI, hospital and complications. Interaction test was performed
between the presence CTO and the different categories of ischemic heart disease e.g.
stable angina, unstable angina, non-STEMI and STEMI.
Results: The total of 91,154 patients were included in the study of which 14,609 had
a CTO.Median follow-upwas 3 years. The total number of eventswas 9084. CTOwas an
independent predictor of mortality (HR 1.29; 95%CI 1.22-1.37; P<0.001). The presence
of CTOwas not associatedwith increasedmortality risk in patientswith stable angina (HR
1.10, (CI95% 0.98-1.48). However, in patients with acute coronary syndromes, CTOwas
associated with increased risk e.g. unstable angina (HR 1.22; 95% CI 1.02-1.48), non-
STEMI (1.39; 95% CI 1.25-1.55) and STEMI (1.62; CI95% 1.46-1.83).
Conclusions: Our study is based on the largest CTO cohort so far. The presence of
CTO is associated with worse long-term survival in patients with acute coronary
syndromes but not in patients with stable angina.
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Background: Chronic total coronary occlusion (CTO) is a frequent ﬁnding in patients
with ischemic heart disease. Our aim was to evaluate the prognostic impact of CTO at
the level of one whole nation on long-term survival in patients with ischemic heart
disease at different ages.
Methods: The study population included all consecutive patients registered in the
SCAAR registry (Swedish Coronary Angiography and Angioplasty Registry) from
2005 to 2012 who underwent angiography or PCI in Sweden. Patients with previous
coronary artery bypass graft surgery were excluded. The patients with CTO and
without CTO (no-CTO) were compared using Cox proportional-hazards regression
adjusted for the following covariates: indication, extent of coronary artery disease,
smoking, hypertension, hyperlipidemia, diabetes, year of intervention, prior infarction,
prior PCI, hospital and complications. Interaction test was performed between the
presence CTO and the different age categories e.g. < 59, 60-69, 70-79 and > 80.
Results: The total of 91,154 patients were included in the study of which 14,609 had
a CTO. Median follow-up was 3 years. The total number of events was 9084. CTO
was an independent predictor of mortality (HR 1.29; 95%CI 1.22-1.37; P<0.001). The
presence of CTO was associated with increased mortality risk in all age groups.
However the risk was substantially higher in younger patients e.g. < 59 (HR 1.66;
95% CI 1.41 -1.97), 60-69 (HR 1.49; 95% CI 1.33 -1.67), 70-79 (HR 1.24; 95% CI
1.14 -1.35) and > 80 (HR 1.15; 95% CI 1.05 -1.28).
Conclusions: Our study is based on the largest CTO cohort so far. The presence of
CTO is associated with worse long-term survival particularly in younger patients with
ischemic heart disease.ovember 1, 2013 j TCT Abstracts/POSTER/Chronic Total Occlusions
